emil kakkis, md, phd | the challenges of managing heterogeneity in rare diseases
Published 5 years ago • 409 plays • Length 23:54Download video MP4
Download video MP3
Similar videos
-
8:49
emil kakkis and max schill
-
54:11
early phase trial designs in rare diseases
-
59:30
study designs for oncology and rare diseases
-
16:40
faster rare disease progress is within our reach with dr. emil kakkis and mary woolley
-
25:04
ultragenyx - kakkis
-
27:44
s1e08: designing early stage clinical trials
-
57:06
optimizing rare disease trials: trial design & execution
-
30:48
designing proof-of-concept clinical trials - ashwin gollerkeri, m.d., pfizer
-
31:11
emil kakkis, m.d., ph.d. - developing treatments for rare diseases
-
1:33
role of patient groups in drug development
-
33:02
special issues in rare disease study design: expert panel
-
3:24
how rare disease treatments get approved
-
36:34
translational medicine symposium 2013: dr. emil kakkis, 3 of 4
-
1:01
designing clinical trials for rare diseases
-
45:54
optimizing clinical trial design with extracted efficacy data
-
1:13
designing clinical trials for children
-
22:01
optimization of clinical trial design for rare disease through modeling: example in duchenne’s
-
40:30
rare disease clinical trials - being informed
-
11:19
fda draft guidance: rare disease clinical trials